Vanguard Investments Australia
IART icon

Vanguard Investments Australia’s Integra LifeSciences IART Stock Holding History

Vanguard Investments Australia’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$296K Hold
16,482
– – ﹤0.01% 1935
2026
Q1 		$155K Buy
+16,482
New +$181K ﹤0.01% 2142

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Investments Australia's IART Position: Q2 2026 in Review

Vanguard Investments Australia held its Integra LifeSciences (IART) position steady in Q2 2026 at 16,482 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #1935.

Vanguard Investments Australia first reported a position in IART in Q1 2026 and has held it in 2 quarters since. 194 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Vanguard Investments Australia held 16,482 shares of Integra LifeSciences worth $296K as of Q2 2026.
  • Vanguard Investments Australia left its Integra LifeSciences share count unchanged in Q2 2026.
  • Integra LifeSciences made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1935 holding.
  • Vanguard Investments Australia first reported a position in Integra LifeSciences in Q1 2026 and has held it in 2 quarters since.
  • 194 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.